Skip to main content

Animations

MJFF Publications

8431 - 8440 of 9140 Results
Title
Year
  • Year
  • 2023
  • 2024
  • 2024
  • 2024
  • 2022
  • 2024
  • 2024
  • 2024
  • 2024
  • 2023
  • Summary Details
    OPEN
    Title: Downregulation of Dickkopf-3, a Wnt antagonist elevated in Alzheimer’s disease, restores synapse integrity and memory in a disease mouse model
    Journal Name: eLife
    Publisher: eLife Sciences Publications, Ltd
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.7554/elife.89453
    Citation Count: 17
  • Summary Details
    OPEN
    Title: AccessPD as a next generation registry to accelerate Parkinson’s disease research
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-024-00651-z
    Citation Count: 3
  • Summary Details
    OPEN
    Title: A topographical atlas of α-synuclein dosage and cell type-specific expression in adult mouse brain and peripheral organs
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-024-00672-8
    Citation Count: 28
  • Summary Details
    OPEN
    Title: Turning alterations detected by mobile health technology in idiopathic REM sleep behavior disorder
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-024-00682-6
    Citation Count: 12
  • Summary Details
    OPEN
    Title: Decreased Water Mobility Contributes To Increased α‐Synuclein Aggregation**
    Journal Name: Angewandte Chemie
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1002/ange.202212063
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Parkinsonism Sac domain mutation in Synaptojanin-1 affects ciliary properties in iPSC-derived dopaminergic neurons
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1073/pnas.2318943121
    Citation Count: 13
  • Summary Details
    OPEN
    Title: Role of GBA variants in Lewy body disease neuropathology
    Journal Name: Acta Neuropathologica
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s00401-024-02699-w
    Citation Count: 23
  • Summary Details
    OPEN
    Title: Associations of sleep disorders with serum neurofilament light chain levels in Parkinson’s disease
    Journal Name: BMC Neurology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s12883-024-03642-y
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Longitudinal cognitive decline characterizes the profile of non-PD-manifest GBA1 mutation carriers
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-024-00706-1
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Interaction of an α-synuclein epitope with HLA-DRB1∗15:01 triggers enteric features in mice reminiscent of prodromal Parkinson’s disease
    Journal Name: Neuron
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.neuron.2023.07.015
    Citation Count: 54
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.